Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

InnaPhase

1998 FOUNDED
M&A STATUS
M&A LATEST DEAL TYPE
$65M LATEST DEAL AMOUNT
Description

Provider of laboratory information management systems for the pharmaceutical industry. The products are used in drug development laboratories and bioanalytical applications.

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Primary Industry
Other Pharmaceuticals and Biotechnology
Acquirer
Primary Office
  • 1601 Cherry Street
  • Suite 1200
  • Philadelphia, PA 19102
  • United States

+1 (215) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore InnaPhase’s full profile, request a free trial.

InnaPhase Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Merger/Acquisition 15-Sep-2004 $65M 000 0000 Completed Clinical Trials - General
1. Later Stage VC (Series D) 07-Jan-2003 000 000 Completed Clinical Trials - General
To view this company’s complete deal history including valuation and funding, request access »

InnaPhase Former Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Edison Partners Venture Capital Minority 000 0000 000000 0
EuclidSR Partners Venture Capital Minority 000 0000 000000 0
LLR Partners PE/Buyout Minority 000 0000 000000 0
NewSpring Capital Growth/Expansion Minority 000 0000 000000 0